OI
38
-4
WFC
80
-2
HPE
42
2
HPQ
59
6
HCP
62
2
PHM
64
-2
TGT
31
4
HES
65
2
SBUX
52
13
LB
49
-14
DRI
60
2
URBN
76
10
MA
67
2
BLK
55
-2
HSY
40
3
F
48
-3
MAC
65
-3
SLG
62
-4
XEL
69
-3
MOS
50
7
OI
38
-4
WFC
80
-2
HPE
42
2
HPQ
59
6
HCP
62
2
PHM
64
-2
TGT
31
4
HES
65
2
SBUX
52
13
LB
49
-14
DRI
60
2
URBN
76
10
MA
67
2
BLK
55
-2
HSY
40
3
F
48
-3
MAC
65
-3
SLG
62
-4
XEL
69
-3
MOS
50
7
Financhill
Back

Alnylam Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
30

ALNY
Alnylam Pharmaceuticals

Last Price:
253.13
Seasonality Move:
7.55%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Sell
30
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $253.07. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $253.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.04 Sell
Relative Strength Index (14 RSI): 44.15 Sell
Chaikin Money Flow: 152237 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (246.3 - 278.6) Sell
Bollinger Bands (100): (248.75 - 281.71) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 248.24 Buy
20-day SMA: 257.83 Sell
50-day SMA: 271.05 Sell
200-day SMA: 213.33 Buy
8-day EMA: 251.28 Buy
20-day EMA: 257.22 Sell
50-day EMA: 263.45 Sell
200-day EMA: 231.88 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):